Lassoued Imen, Mora Leticia, Barkia Ahmed, Aristoy M-Concepción, Nasri Moncef, Toldrá Fidel
Laboratory of Enzyme Engineering and Microbiology, University of Sfax, National Engineering School of Sfax, B.P. 1173-3038 Sfax, Tunisia.
Instituto de Agroquímica y Tecnología de Alimentos (CSIC), Avenue Agustín Escardino 7, Paterna, 46980 Valencia, Spain.
J Proteomics. 2015 Oct 14;128:8-17. doi: 10.1016/j.jprot.2015.06.016. Epub 2015 Jul 4.
Thornback ray skin gelatin has been hydrolyzed with two different proteases in order to obtain peptides with ACE inhibitory and antioxidant activity. Hydrolysates with protease from Bacillus subtilis A26 (TRGH-A26) displayed ACE inhibitory activity with an IC50 value of 0.94 μg/μL whereas Neutrase® hydrolysate from Bacillus amyloliquefaciens (TRGH-Neutrase) showed an IC50 value of 2.07 μg/μL. Regarding antioxidant activity, IC50 values of 1.98 and 21.2 μg/μL in TRGH-A26 and TRGH-Neutrase, respectively, were obtained using the DPPH radical-scavenging assay. The most active fractions identified by size-exclusion chromatography were further purified by RP-HPLC and analysed using nanoESI-LC-MS/MS to identify the sequence of the peptides. APGAP was the most active peptide inTRGH-A26 for ACE inhibitory activity with an IC50 value of 170 μM, whereas GIPGAP showed the best ACE inhibitory activity in TRGH-Neutrase sample with an IC50 value of 27.9 μM. The highest antioxidant activity was identified in peptide AVGAT, showing a 33% of activity at 3mg/mL using the DPPH radical-scavenging assay. The obtained results proved the potential of thornback ray skin gelatin hydrolysates as a source of bioactive peptides.
This study describes a peptidomic approach for the identification of ACE-inhibitory and antioxidant peptides generated from thornback ray gelatin (Raja clavata) hydrolysates from Bacillus subtilis A26 and Bacillus amyloliquefaciens Neutrase® enzymes and expose the potential of thornback ray gelatin hydrolysate as a source of bioactive peptides. In this sense, the decrease of systolic blood pressure is one of the main measurements considered in public health for the treatment of cardiovascular diseases, stroke and even end-stage renal disease. Traditionally, synthetic drugs such as captopril and enalapril have been used as ACE inhibitors despite their secondary effects, but the finding of new sources for the generation of natural bioactive peptides such as thornback ray muscle results is very important in the knowledge of less hostile but highly effective antihypertensive peptides as well as the development of new uses for waste and by-products generated from marine products, helping to solve the already existing environmental problem affecting this industry.
为了获得具有ACE抑制和抗氧化活性的肽,已用两种不同的蛋白酶水解了棘背鳐皮明胶。枯草芽孢杆菌A26蛋白酶水解产物(TRGH - A26)表现出ACE抑制活性,IC50值为0.94μg/μL,而解淀粉芽孢杆菌的中性蛋白酶水解产物(TRGH - Neutrase)的IC50值为2.07μg/μL。关于抗氧化活性,使用DPPH自由基清除试验在TRGH - A26和TRGH - Neutrase中分别获得的IC50值为1.98和21.2μg/μL。通过尺寸排阻色谱法鉴定出的最具活性的级分通过反相高效液相色谱进一步纯化,并使用纳升电喷雾液相色谱 - 串联质谱进行分析以鉴定肽的序列。APGAP是TRGH - A26中ACE抑制活性最高的肽,IC50值为170μM,而GIPGAP在TRGH - Neutrase样品中表现出最佳的ACE抑制活性,IC50值为27.9μM。在肽AVGAT中鉴定出最高的抗氧化活性,使用DPPH自由基清除试验在3mg/mL时显示出33%的活性。所得结果证明了棘背鳐皮明胶水解产物作为生物活性肽来源的潜力。
本研究描述了一种肽组学方法,用于鉴定由枯草芽孢杆菌A26和解淀粉芽孢杆菌中性蛋白酶产生的棘背鳐明胶(Raja clavata)水解产物中的ACE抑制肽和抗氧化肽,并揭示了棘背鳐明胶水解产物作为生物活性肽来源的潜力。从这个意义上说,收缩压的降低是公共卫生中治疗心血管疾病、中风甚至终末期肾病时考虑的主要指标之一。传统上,尽管有副作用,但卡托普利和依那普利等合成药物一直被用作ACE抑制剂,但是找到新的天然生物活性肽来源,如棘背鳐肌肉的研究结果,对于了解低毒但高效的抗高血压肽以及开发海产品产生的废物和副产品的新用途非常重要,有助于解决影响该行业的现有环境问题。